NEW DELHI/MUMBAI (Reuters) – India’s drugs regulator has asked all states to enforce a court directive prohibiting online medicine sales, a senior government official said on Wednesday, raising industry concerns it could disrupt some online businesses. FILE PHOTO: People walk past a chemist shop at a market in Mumbai, India, June 24, 2014. REUTERS/Danish Siddiqui/File
0 Comments
Britain’s Prime Minister Boris Johnson visits a veterans centre in Salisbury, Britain, December 3, 2019. REUTERS/Hannah McKay/Pool LONDON (Reuters) – Prime Minister Boris Johnson’s Conservative Party has maintained its nine-point lead over the opposition Labour Party ahead of Britain’s Dec. 12 election, according to an opinion poll published by YouGov for The Times and Sky
0 Comments
FILE PHOTO: A man takes a picture of Paul Gaugin’s “Te Bourao II” (The Purao Tree) painting (1897) at Artcurial’s auction house in Paris, France, October 3, 2019. REUTERS/ Christian Hartmann PARIS (Reuters) – A painting by French post-impressionist artist Paul Gauguin fetched 9.5 million euros ($10.5 million) in a Paris auction on Tuesday. “Te
0 Comments
VERONA, Italy (Reuters) – Italian photographer Paolo Roversi took inspiration from William Shakespeare’s “Romeo and Juliet” for the 2020 Pirelli calendar, which features Hollywood names such as Emma Watson and Kristen Stewart as well as transgender model and actor Indya Moore. Set in Verona, where Shakespeare’s play takes place, the calendar, entitled “Looking for Juliet”,
0 Comments
LONDON (Reuters) – Britain holds an election on Dec. 12, a political gamble by Prime Minister Boris Johnson who sees it as his best chance to break the deadlock in parliament over Brexit. FILE PHOTO: Britain’s Prime Minister Boris Johnson visits a Christmas market in Salisbury, Britain, December 3, 2019. REUTERS/Hannah McKay/Pool The parties are
0 Comments
FILE PHOTO: An employee of Clever Leaves company works inside a cannabis plantation, at a greenhouse in Pesca, Colombia, Colombia October 2, 2019. REUTERS/Luisa Gonzalez RIO DE JANEIRO (Reuters) – Brazil has approved medicinal cannabis-based products, the country’s pharmaceutical regulator Anvisa said on Tuesday, becoming the latest drug-ravaged Latin American nation to sign off on
0 Comments
LONDON (Reuters) – From Haiti’s devastating earthquake to war in Syria, Reuters photographers have covered the biggest news stories of the decade, capturing images of armed conflict, natural disasters, the plight of migrants and the drama of sport. Anti-government protesters celebrate inside Tahrir Square after the announcement of Egyptian President Hosni Mubarak’s resignation in Cairo,
0 Comments
GENEVA (Reuters) – Climate change is harming human health as more people suffer from heat stress, extreme weather and mosquito-borne diseases including malaria, the World Health Organization (WHO) said on Tuesday. FILE PHOTO: A logo is pictured on the World Health Organization (WHO) headquarters in Geneva, Switzerland, November 22, 2017. REUTERS/Denis Balibouse The U.N. agency,
0 Comments
(Reuters) – The chief executive officer of OxyContin-maker Purdue Pharma LP should not collect a potential $1.3 million bonus when he has been accused of contributing to the opioid epidemic, a group of state attorneys general said in a court filing on Monday. FILE PHOTO: Bottles of prescription painkiller OxyContin made by Purdue Pharma LP
0 Comments
(Reuters) – The Trump administration is considering scaling back intellectual-property protections for biologic drugs by big drugmakers to help win Democratic support for a new trade pact with Mexico and Canada, the Wall Street Journal reported, citing people familiar with the matter. Democrats are pushing the administration to reduce the length of time that leading
0 Comments
LONDON (Reuters) – The leak and distribution of classified British-U.S. trade documents online resembles a disinformation campaign uncovered this year that originated in Russia, according to experts who say it could signal foreign interference in Britain’s election. FILE PHOTO: Britain’s opposition Labour Party leader Jeremy Corbyn holds documents as he speaks during a general election
0 Comments
(Reuters) – The U.S. FDA denied Lexicon Pharmaceuticals Inc’s appeal against the rejection of its add-on treatment for type 1 diabetes, marking the company’s third major setback this year and sending its shares plunging 18% on Monday. Lexicon said it intended to reappeal the decision against Zynquista’s approval with the FDA’s Center for Drug Evaluation
0 Comments